Robert Davis, Merck CEO
FDA authorizes new Merck Covid-19 pill despite scientists' concerns on its mechanism of action
The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck.
While Pfizer’s antiviral may …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
